Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Assessing breathing effort with nasal pressure during different oxygen treatments

Official title: Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments: a Prospective Physiological Study

Run by Capital Medical University · NCT06970990 · Data updated 2026-11-12

This study is testing if measuring nasal pressure can help doctors understand how hard patients with breathing problems are working to breathe when using different types of oxygen therapy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment26 (estimated)
SponsorCapital Medical University
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 20, 2025
Main results expectedNovember 30, 2025
Study endsDecember 30, 2025
Registry record updatedMay 22, 2025
Trial IDNCT06970990 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults in the ICU who are stable enough to tolerate various forms of oxygen therapy without requiring mechanical ventilation.

Probably not a fit

Patients who are hemodynamically unstable or require mechanical ventilation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how various oxygen therapy methods, such as nasal cannula and high-flow nasal cannula, affect the relationship between nasal pressure and esophageal pressure in patients with respiratory distress. By monitoring these pressures, the study aims to evaluate the feasibility of using nasal pressure as a non-invasive indicator for assessing inspiratory effort, potentially replacing esophageal manometry in clinical settings. The research will also analyze the impact of different oxygen therapies on respiratory mechanics and patient comfort, providing insights for personalized oxygen treatment regimens.

Why it matters

Potential benefit: If successful, this study could lead to improved non-invasive monitoring of respiratory effort in critically ill patients, enhancing their treatment and comfort.

How similar studies have gone: While the approach of using nasal pressure for monitoring is promising, it is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. No mechanical ventilation required,Able to tolerate oxygen therapy via nasal cannula, standard face mask, or nasal high-flow oxygen therapy;
2. Respiratory stability:Capable of spontaneous breathing with effective cough for secretion clearance.Oxygen saturation (SpO₂) \> 90% or PaO₂/FiO₂ ≥ 150 mmHg when receiving nasal cannula oxygen at 3 L/min;
3. Hemodynamic stability:Heart rate (HR) ≤ 120 bpm;Systolic blood pressure (SBP) 90-150 mmHg;No vasoactive medications OR norepinephrine dosage \< 0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
4. Metabolic stability;
5. Compliance with medical instructions.Able to follow prescribed tasks.Esophageal pressure monitoring catheter already in place;
6. Patient or legal guardian agrees to participate and has signed the informed consent form.

Exclusion Criteria:

1. Age \< 18 years;
2. Pregnancy;
3. Hemodynamic instability:Mean arterial pressure (MAP) \< 60 mmHg.Heart rate (HR) \> 120 bpm or \< 60 bpm;
4. Respiratory instability:Respiratory rate (RR) \> 35 bpm.Oxygen saturation (SpO₂) \< 90%;
5. Neuromuscular diseases or phrenic nerve injury;
6. Recent trauma or surgery involving the trachea, esophagus, neck, or chest.Contraindications to esophageal catheter placement or inability to monitor esophageal pressure;
7. Nasal obstruction or anatomical abnormalities:Complete nasal obstruction.Severe anatomical abnormalities (e.g., severe septal deviation, nasal polyps, or tumors) preventing catheter placement or compromising ventilation;
8. High-risk craniofacial conditions:Severe facial trauma or skull base fracture with risk of catheter misplacement into the intracranial space.Active epistaxis or incomplete healing after nasal surgery;
9. Bleeding risk:Severe coagulopathy.Esophageal/gastric varices or other conditions predisposing to hemorrhage.

Where it's running

  • Beijing Shijitan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Jian-Xin Zhou, MD, PhD — Capital Medical University
  • Study coordinator: Jian-Xin Zhou, MD, PhD
  • Email: zhoujx.cn@icloud.com
  • Phone: 8610 6392 6666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.